Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis


WINTHROP K. L., PARK S., Gül A., CARDIEL M. H., GOMEZ-REINO J. J., TANAKA Y., ...More

ANNALS OF THE RHEUMATIC DISEASES, vol.75, no.6, pp.1133-1138, 2016 (SCI-Expanded) identifier identifier identifier

Abstract

Objectives To evaluate the risk of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with tofacitinib.